-
1
-
-
0027987849
-
Randomised trial of cholesterol lowering in 4444 patients with coronary heart disease: The Scandinavian Simvastatin Survival Study (4S)
-
Randomised trial of cholesterol lowering in 4444 patients with coronary heart disease: The Scandinavian Simvastatin Survival Study (4S). Lancet 1994;344:1383-9.
-
(1994)
Lancet
, vol.344
, pp. 1383-1389
-
-
-
2
-
-
0032487931
-
Prevention of cardiovascular events and death with pravastatin in patients with coronary heart disease and a broad range of initial cholesterol levels. The long-term intervention with pravastatin in ischaemic disease (LIPID) Study Group
-
Prevention of cardiovascular events and death with pravastatin in patients with coronary heart disease and a broad range of initial cholesterol levels. The Long-Term Intervention with Pravastatin in Ischaemic Disease (LIPID) Study Group. N Engl J Med 1998;339:1349-57.
-
(1998)
N Engl J Med
, vol.339
, pp. 1349-1357
-
-
-
3
-
-
0032572086
-
Primary prevention of acute coronary events with lovastatin in men and women with average cholesterol levels: Results of AFCAPS/TexCAPS
-
DOI 10.1001/jama.279.20.1615
-
Downs JR, Clearfield M, Weis S, et al. Primary prevention of acute coronary events with lovastatin in men and women with average cholesterol levels: Results of AFCAPS/TexCAPS. Air Force/Texas Coronary Atherosclerosis Prevention Study. JAMA 1998;279:1615-22. (Pubitemid 28248586)
-
(1998)
Journal of the American Medical Association
, vol.279
, Issue.20
, pp. 1615-1622
-
-
Downs, J.R.1
Clearfield, M.2
Weis, S.3
Whitney, E.4
Shapiro, D.R.5
Beere, P.A.6
Langendorfer, A.7
Stein, E.A.8
Kruyer, W.9
Gotto Jr., A.M.10
-
4
-
-
0342981862
-
The effect of pravastatin on coronary events after myocardial infarction in patients with average cholesterol levels
-
DOI 10.1056/NEJM199610033351401
-
Sacks FM, Pfeffer MA, Moye LA, et al. The effect of pravastatin on coronary events after myocardial infarction in patients with average cholesterol levels. Cholesterol and Recurrent Events Trial investigators. N Engl J Med 1996;335:1001-9. (Pubitemid 26338729)
-
(1996)
New England Journal of Medicine
, vol.335
, Issue.14
, pp. 1001-1009
-
-
Sacks, F.M.1
Pfeffer, M.A.2
Moye, L.A.3
Rouleau, J.L.4
Rutherford, J.D.5
Cole, T.G.6
Brown, L.7
Warnica, J.W.8
Arnold, J.M.O.9
Wun, C.-C.10
Davis, B.R.11
Braunwald, E.12
-
5
-
-
0028883828
-
Prevention of coronary heart disease with pravastatin in men with hypercholesterolemia. West of scotland coronary prevention study group
-
Shepherd J, Cobbe SM, Ford I, et al. Prevention of coronary heart disease with pravastatin in men with hypercholesterolemia. West of Scotland Coronary Prevention Study Group. N Engl J Med 1995;333:1301-7.
-
(1995)
N Engl J Med
, vol.333
, pp. 1301-1307
-
-
Shepherd, J.1
Cobbe, S.M.2
Ford, I.3
-
6
-
-
0025353476
-
Changes in risk factors and the decline in mortality from cardiovascular disease. The Framingham heart study
-
Sytkowski PA, Kannel WB, D'Agostino RB. Changes in risk factors and the decline in mortality from cardiovascular disease. The Framingham Heart Study. N Engl J Med 1990;322:1635-41. (Pubitemid 20171587)
-
(1990)
New England Journal of Medicine
, vol.322
, Issue.23
, pp. 1635-1641
-
-
Sytkowski, P.A.1
Kannel, W.B.2
D'Agostino, R.B.3
-
7
-
-
0035897696
-
Expert panel on detection evaluation and treatment of high blood cholesterol in adults. Executive summary of the third report of the national cholesterol education program (ncep) expert panel on detection, evaluation, and treatment of high blood cholesterol in adults (Adult Treatment Panel III)
-
Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults. Executive Summary of The Third Report of The National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol In Adults (Adult Treatment Panel III). JAMA 2001;285:2486-97.
-
(2001)
JAMA
, vol.285
, pp. 2486-2497
-
-
-
8
-
-
38049034068
-
Pleiotropic effects of statin therapy: Molecular mechanisms and clinical results
-
Wang CY, Liu PY, Liao JK. Pleiotropic effects of statin therapy: Molecular mechanisms and clinical results. Trends Mol Med 2008;14:37-44.
-
(2008)
Trends Mol Med
, vol.14
, pp. 37-44
-
-
Wang, C.Y.1
Liu, P.Y.2
Liao, J.K.3
-
9
-
-
16544374872
-
Inflammation in atherothrombosis: How to use highsensitivity C-reactive protein (hsCRP) in clinical practice
-
Ridker PM. Inflammation in atherothrombosis: How to use highsensitivity C-reactive protein (hsCRP) in clinical practice. Am Heart Hosp J 2004;2:4-9.
-
(2004)
Am Heart Hosp J
, vol.2
, pp. 4-9
-
-
Ridker, P.M.1
-
10
-
-
20444402764
-
CDC/AHA Workshop on Markers of Inflammation and Cardiovascular Disease: Application to Clinical and Public Health Practice: Report from the clinical practice discussion group
-
Smith SC Jr, Anderson JL, Cannon RO III, et al. CDC/AHA Workshop on Markers of Inflammation and Cardiovascular Disease: Application to Clinical and Public Health Practice: Report from the clinical practice discussion group. Circulation 2004;110:e550-3.
-
(2004)
Circulation
, vol.110
-
-
Smith Jr., S.C.1
Anderson, J.L.2
Cannon III, R.O.3
-
11
-
-
4944261232
-
2 adds to risk prediction of incident coronary events by C-reactive protein in apparently healthy middle-aged men from the general population: Results from the 14-year follow-up of a large cohort from Southern Germany
-
DOI 10.1161/01.CIR.0000143377.53389.C8
-
Koenig W, Khuseyinova N, Lowel H, Trischler G, Meisinger C. Lipoprotein-associated phospholipase A2 adds to risk prediction of incident coronary events by C-reactive protein in apparently healthy middle-aged men from the general population: Results from the 14-year follow-up of a large cohort from southern Germany. Circulation 2004;110:1903-8. (Pubitemid 39331899)
-
(2004)
Circulation
, vol.110
, Issue.14
, pp. 1903-1908
-
-
Koenig, W.1
Khuseyinova, N.2
Lowel, H.3
Trischler, G.4
Meisinger, C.5
-
12
-
-
39149142513
-
Antiarrhythmic Effect of Statin Therapy and Atrial Fibrillation. A Meta-Analysis of Randomized Controlled Trials
-
DOI 10.1016/j.jacc.2007.09.063, PII S0735109707037795
-
Fauchier L, Pierre B, de Labriolle A, Grimard C, Zannad N, Babuty D. Antiarrhythmic effect of statin therapy and atrial fibrillation a meta-analysis of randomized controlled trials. J Am Coll Cardiol 2008;51:828-35. (Pubitemid 351255618)
-
(2008)
Journal of the American College of Cardiology
, vol.51
, Issue.8
, pp. 828-835
-
-
Fauchier, L.1
Pierre, B.2
De Labriolle, A.3
Grimard, C.4
Zannad, N.5
Babuty, D.6
-
13
-
-
38349150595
-
Experimental and clinical basis for the use of statins in patients with ischemic and nonischemic cardiomyopathy
-
Ramasubbu K, Estep J, White DL, Deswal A, Mann DL. Experimental and clinical basis for the use of statins in patients with ischemic and nonischemic cardiomyopathy. J Am Coll Cardiol 2008;51:415-26.
-
(2008)
J Am Coll Cardiol
, vol.51
, pp. 415-426
-
-
Ramasubbu, K.1
Estep, J.2
White, D.L.3
Deswal, A.4
Mann, D.L.5
-
14
-
-
6944240055
-
Early withdrawal of statin therapy in patients with non-ST-segment elevation myocardial infarction: National registry of myocardial infarction
-
DOI 10.1001/archinte.164.19.2162
-
Spencer FA, Fonarow GC, Frederick PD, et al. Early withdrawal of statin therapy in patients with non-ST-segment elevation myocardial infarction: National registry of myocardial infarction. Arch Intern Med 2004;164:2162-8. (Pubitemid 39410807)
-
(2004)
Archives of Internal Medicine
, vol.164
, Issue.19
, pp. 2162-2168
-
-
Spencer, F.A.1
Fonarow, G.C.2
Frederick, P.D.3
Wright, R.S.4
Every, N.5
Goldberg, R.J.6
Gore, J.M.7
Dong, W.8
Becker, R.C.9
French, W.10
-
15
-
-
15944410609
-
Intensive lipid lowering with atorvastatin in patients with stable coronary disease
-
DOI 10.1056/NEJMoa050461
-
LaRosa J, Grundy SM, Waters DD, et al; for the Treating to New Targets (TNT) Investigators. Intensive lipid lowering with atorvastatin in patients with stable coronary disease. N Engl J Med 2005;352:1425-35. (Pubitemid 40471450)
-
(2005)
New England Journal of Medicine
, vol.352
, Issue.14
, pp. 1425-1435
-
-
LaRosa, J.C.1
Grundy, S.M.2
Waters, D.D.3
Shear, C.4
Barter, P.5
Fruchart, J.-C.6
Gotto, A.M.7
Greten, H.8
Kastelein, J.J.P.9
Shepherd, J.10
Wenger, N.K.11
-
16
-
-
0029054734
-
Molecular bases of the acute coronary syndromes
-
Libby P. Molecular bases of the acute coronary syndromes. Circulation 1995;91:2844-50.
-
(1995)
Circulation
, vol.91
, pp. 2844-2850
-
-
Libby, P.1
-
17
-
-
34247262523
-
Prevalence and predictors of poor antihypertensive medication adherence in an urban health clinic setting
-
Hyre A, Krousel-Wood MA, Muntner P, Kawasake L, DeSalvo KB. Prevalence and predictors of poor antihypertensive medication adherence in an urban health clinic setting. J Clin Hypertens 2007;9:179-86.
-
(2007)
J Clin Hypertens
, vol.9
, pp. 179-186
-
-
Hyre, A.1
Krousel-Wood, M.A.2
Muntner, P.3
Kawasake, L.4
Desalvo, K.B.5
-
19
-
-
0037075262
-
Cerivastatin and reports of fatal rhabdomyolysis
-
Staffa JA, Chang J, Green L. Cerivastatin and reports of fatal rhabdomyolysis. N Engl J Med 2002;346:539-40.
-
(2002)
N Engl J Med
, vol.346
, pp. 539-540
-
-
Staffa, J.A.1
Chang, J.2
Green, L.3
-
20
-
-
0038645309
-
Comparison of the efficacy and safety of rosuvastatin versus atorvastatin, simvastatin, and pravastatin across doses (STELLAR*trial)
-
DOI 10.1016/S0002-9149(03)00530-7
-
Jones PH, Davidson MH, Stein EA, et al. Comparison of the efficacy and safety of rosuvastatin versus atorvastatin, simvastatin, and pravastatin across doses (STELLAR* Trial). Am J Cardiol 2003;92:152-60. (Pubitemid 36835963)
-
(2003)
American Journal of Cardiology
, vol.92
, Issue.2
, pp. 152-160
-
-
Jones, P.H.1
Davidson, M.H.2
Stein, E.A.3
Bays, H.E.4
McKenney, J.M.5
Miller, E.6
Cain, V.A.7
Blasetto, J.W.8
-
21
-
-
11144355354
-
Intensive versus Moderate Lipid Lowering with Statins after Acute Coronary Syndromes
-
DOI 10.1056/NEJMoa040583
-
Cannon CP, Braunwald E, McCabe CH, et al. Intensive versus moderate lipid lowering with statins after acute coronary syndromes. N Engl J Med 2004;350:1495-504. (Pubitemid 38477774)
-
(2004)
New England Journal of Medicine
, vol.350
, Issue.15
, pp. 1495-1504
-
-
Cannon, C.P.1
Braunwald, E.2
McCabe, C.H.3
Rader, D.J.4
Rouleau, J.L.5
Belder, R.6
Joyal, S.V.7
Hill, K.A.8
Pfeffer, M.A.9
Skene, A.M.10
-
22
-
-
0037111890
-
Efficacy and safety of ezetimibe added to ongoing statin therapy for treatment of patients with primary hypercholesterolemia
-
DOI 10.1016/S0002-9149(02)02774-1, PII S0002914902027741
-
Gagne C, Bays HE, Weiss SR, et al. Efficacy and safety of ezetimibe added to ongoing statin therapy for treatment of patients with primary hypercholesterolemia. Am J Cardiol 2002;90:1084-91. (Pubitemid 35339435)
-
(2002)
American Journal of Cardiology
, vol.90
, Issue.10
, pp. 1084-1091
-
-
Gagne, C.1
Bays, H.E.2
Weiss, S.R.3
Mata, P.4
Quinto, K.5
Melino, M.6
Cho, M.7
Musliner, T.A.8
Gumbiner, B.9
-
24
-
-
34547954921
-
A new perspective on nonprescription statins: An opportunity for patient education and involvement
-
DOI 10.1016/j.amjcard.2007.06.009, PII S0002914907012349
-
Fuster V. A new perspective on nonprescription statins: An opportunity for patient education and involvement. Am J Cardiol 2007;100:907-10. (Pubitemid 47268288)
-
(2007)
American Journal of Cardiology
, vol.100
, Issue.5
, pp. 907-910
-
-
Fuster, V.1
-
25
-
-
41949093962
-
Nonprescription statins: Not ready for prime time
-
DOI 10.1016/j.amjcard.2007.09.112, PII S0002914907020966
-
Whayne TF Jr. Nonprescription statins: Not ready for prime time. Am J Cardiol 2008;101:745-746; author reply 746. (Pubitemid 351625075)
-
(2008)
American Journal of Cardiology
, vol.101
, Issue.5
, pp. 745-746
-
-
Whayne Jr., T.F.1
-
26
-
-
34247639532
-
Effect of coenzyme Q10 on myopathic symptoms in patients treated with statins
-
DOI 10.1016/j.amjcard.2006.12.063, PII S000291490700255X
-
Caso G, Kelly P, McNurlan MA, Lawson WE. Effect of coenzyme q10 on myopathic symptoms in patients treated with statins. Am J Cardiol 2007;99:1409-12. (Pubitemid 46686635)
-
(2007)
American Journal of Cardiology
, vol.99
, Issue.10
, pp. 1409-1412
-
-
Caso, G.1
Kelly, P.2
McNurlan, M.A.3
Lawson, W.E.4
-
27
-
-
34249826635
-
The role of coenzyme Q10 in statin-associated myopathy. A systematic review
-
DOI 10.1016/j.jacc.2007.02.049, PII S0735109707010546
-
Marcoff L, Thompson PD. The role of coenzyme Q10 in statinassociated myopathy: a systematic review. J Am Coll Cardiol 2007;49:2231-7. (Pubitemid 46856819)
-
(2007)
Journal of the American College of Cardiology
, vol.49
, Issue.23
, pp. 2231-2237
-
-
Marcoff, L.1
Thompson, P.D.2
|